scispace - formally typeset
A

Andra H. James

Researcher at Duke University

Publications -  225
Citations -  14152

Andra H. James is an academic researcher from Duke University. The author has contributed to research in topics: Pregnancy & Von Willebrand disease. The author has an hindex of 51, co-authored 214 publications receiving 12263 citations. Previous affiliations of Andra H. James include University of North Carolina at Chapel Hill & University of Virginia.

Papers
More filters
Journal ArticleDOI

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.

TL;DR: A population-based study to estimate the relative risk and incidence of venous thromboembolism during pregnancy and the postpartum period within a well-defined geographic area and to describe trends in incidence over time is performed.
Journal ArticleDOI

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

TL;DR: This document summarizes needs for further research in VWF, VWD and bleeding disorders, including clinical research to obtain more objective information about bleeding symptoms, advancements in diagnostic and therapeutic tools, and enhancement in the education and training of clinicians and scientists in bleeding and thrombotic disorders.
Journal ArticleDOI

Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.

TL;DR: The incidence of pregnancy-related venous thromboembolism was higher than generally quoted and women ages 35 and older, black women, and women with certain medical conditions and obstetric complications appear to be at increased risk.
Journal ArticleDOI

Incidence and risk factors for stroke in pregnancy and the puerperium.

TL;DR: The incidence, mortality and disability from pregnancy related-stroke are higher than previously reported, and African-American women are at an increased risk, as are women aged 35 years and older.